Author details

Full Name

Preeti Ahuja

Affiliation

David Geffen School of Medicine, University of California at Los Angeles

ORCID

Career Start Year

2004

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37399400	Comprehensive tissue deconvolution of cell-free DNA by deep learning for disease diagnosis and monitoring.	Proc Natl Acad Sci U S A	2023
37399400	Comprehensive tissue deconvolution of cell-free DNA by deep learning for disease diagnosis and monitoring.	Proc Natl Acad Sci U S A	2023
36175411	Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer.	Nat Commun	2022
36175411	Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer.	Nat Commun	2022
32130048	Influence of the Location and Zone of Tumor in Prostate Cancer Detection and Localization on 3-T Multiparametric MRI Based on PI-RADS Version 2.	AJR Am J Roentgenol	2020
32130048	Influence of the Location and Zone of Tumor in Prostate Cancer Detection and Localization on 3-T Multiparametric MRI Based on PI-RADS Version 2.	AJR Am J Roentgenol	2020
32755166	3-T Multiparametric MRI Followed by In-Bore MR-Guided Biopsy for Detecting Clinically Significant Prostate Cancer After Prior Negative Transrectal Ultrasound-Guided Biopsy.	AJR Am J Roentgenol	2020
32921565	Efficacy of 3T Multiparametric MR Imaging followed by 3T in-Bore MR-Guided Biopsy for Detection of Clinically Significant Prostate Cancer Based on PIRADSv2.1 Score.	J Vasc Interv Radiol	2020
32755166	3-T Multiparametric MRI Followed by In-Bore MR-Guided Biopsy for Detecting Clinically Significant Prostate Cancer After Prior Negative Transrectal Ultrasound-Guided Biopsy.	AJR Am J Roentgenol	2020
32921565	Efficacy of 3T Multiparametric MR Imaging followed by 3T in-Bore MR-Guided Biopsy for Detection of Clinically Significant Prostate Cancer Based on PIRADSv2.1 Score.	J Vasc Interv Radiol	2020
30685078	Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer.	Eur Urol	2019
30460528	Characteristics of missed prostate cancer lesions on 3T multiparametric-MRI in 518 patients: based on PI-RADSv2 and using whole-mount histopathology reference.	Abdom Radiol (NY)	2019
30509763	Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging.	Eur Urol	2019
30069968	A system using patient-specific 3D-printed molds to spatially align in vivo MRI with ex vivo MRI and whole-mount histopathology for prostate cancer research.	J Magn Reson Imaging	2019
30142318	PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.	J Urol	2019
30577397	PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.	J Urol	2019
30273608	Three Tesla Multiparametric Magnetic Resonance Imaging: Comparison of Performance with and without Endorectal Coil for Prostate Cancer Detection, PI-RADSâ¿¢ version 2 Category and Staging with Whole Mount Histopathology Correlation.	J Urol	2019
30685078	Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer.	Eur Urol	2019
30847565	The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas.	Abdom Radiol (NY)	2019
30995090	Detection and Localization of Prostate Cancer at 3-T Multiparametric MRI Using PI-RADS Segmentation.	AJR Am J Roentgenol	2019
30069968	A system using patient-specific 3D-printed molds to spatially align in vivo MRI with ex vivo MRI and whole-mount histopathology for prostate cancer research.	J Magn Reson Imaging	2019
30142318	PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.	J Urol	2019
30995090	Detection and Localization of Prostate Cancer at 3-T Multiparametric MRI Using PI-RADS Segmentation.	AJR Am J Roentgenol	2019
30847565	The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas.	Abdom Radiol (NY)	2019
30577397	PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.	J Urol	2019
30460528	Characteristics of missed prostate cancer lesions on 3T multiparametric-MRI in 518 patients: based on PI-RADSv2 and using whole-mount histopathology reference.	Abdom Radiol (NY)	2019
30509763	Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging.	Eur Urol	2019
30273608	Three Tesla Multiparametric Magnetic Resonance Imaging: Comparison of Performance with and without Endorectal Coil for Prostate Cancer Detection, PI-RADSâ¿¢ version 2 Category and Staging with Whole Mount Histopathology Correlation.	J Urol	2019
29460041	Building a high-resolution T2-weighted MR-based probabilistic model of tumor occurrence in the prostate.	Abdom Radiol (NY)	2018
29460041	Building a high-resolution T2-weighted MR-based probabilistic model of tumor occurrence in the prostate.	Abdom Radiol (NY)	2018
23589024	Divergent mitochondrial biogenesis responses in human cardiomyopathy.	Circulation	2013
23589024	Divergent mitochondrial biogenesis responses in human cardiomyopathy.	Circulation	2013
21543616	Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration.	J Neurosci	2011
21543616	Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration.	J Neurosci	2011
20364083	Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice.	J Clin Invest	2010
20364083	Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice.	J Clin Invest	2010
18849322	Essential role of developmentally activated hypoxia-inducible factor 1alpha for cardiac morphogenesis and function.	Circ Res	2008
18849322	Essential role of developmentally activated hypoxia-inducible factor 1alpha for cardiac morphogenesis and function.	Circ Res	2008
17429040	Cardiac myocyte cell cycle control in development, disease, and regeneration.	Physiol Rev	2007
17429040	Cardiac myocyte cell cycle control in development, disease, and regeneration.	Physiol Rev	2007
17316608	Re-expression of proteins involved in cytokinesis during cardiac hypertrophy.	Exp Cell Res	2007
17316608	Re-expression of proteins involved in cytokinesis during cardiac hypertrophy.	Exp Cell Res	2007
16739252	Probing the role of septins in cardiomyocytes.	Exp Cell Res	2006
16739252	Probing the role of septins in cardiomyocytes.	Exp Cell Res	2006
16249673	Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta.	Anesthesiology	2005
16249673	Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta.	Anesthesiology	2005
15226401	Sequential myofibrillar breakdown accompanies mitotic division of mammalian cardiomyocytes.	J Cell Sci	2004
15226401	Sequential myofibrillar breakdown accompanies mitotic division of mammalian cardiomyocytes.	J Cell Sci	2004

1 - 48 of 48

Yawen Tang

University of Alabama at Birmingham, 1670 University Boulevard

Career Start Year 2016

Number of shared co-authors 0

Yang Zhou

University of Alabama at Birmingham

Career Start Year 2015

Number of shared co-authors 0

Kevin Thai

Sunnybrook Research Institute

Career Start Year 2012

Number of shared co-authors 1

James L Engel

David Geffen School of Medicine, University of California los angeles

Career Start Year 2009

Number of shared co-authors 0

Paola Cattaneo

Humanitas Clinical and Research Center-IRCCS

Career Start Year 2009

Number of shared co-authors 0

Eric Zhang

University of Alabama at Birmingham.

Career Start Year 2008

Number of shared co-authors 0

Pingzhu Zhou

Boston Children's Hospital

Career Start Year 2007

Number of shared co-authors 0

Wuqiang Zhu

Mayo Clinic

Career Start Year 2006

Number of shared co-authors 1

Yu Huang

Gladstone Institutes San Francisco

Career Start Year 2004

Number of shared co-authors 0

Li Zhang

Brigham and Women's Hospital and Harvard Medical School

Career Start Year 2003

Number of shared co-authors 0

Alexander von Gise

Hannover Medical School

Career Start Year 2001

Number of shared co-authors 0

Arun Padmanabhan

Gladstone Institutes San Francisco

Career Start Year 2001

Number of shared co-authors 0

Kevin Bersell

Vanderbilt University

Career Start Year 2001

Number of shared co-authors 0

Mohit Jain

Cumming School of Medicine, University of Calgary, 0 Hospital Drive NW

Career Start Year 2000

Number of shared co-authors 0

Javier E L??pez

and Cardiovascular Research Institute, University of California davis

Career Start Year 1998

Number of shared co-authors 0

Julie R McMullen

Baker Heart and Diabetes Institute

Career Start Year 1998

Number of shared co-authors 0

Bin Zhou

The Central Hospital of Shaoyang

Career Start Year 1998

Number of shared co-authors 0

Anthony O Gramolini

University of Toronto, University Avenue

Career Start Year 1996

Number of shared co-authors 2

Neil C Chi

University of California San Diego

Career Start Year 1995

Number of shared co-authors 0

Robert Passier

University of Twente

Career Start Year 1995

Number of shared co-authors 0

Reza Ardehali

University of California los angeles

Career Start Year 1993

Number of shared co-authors 1

Qing Ma

Boston Children's Hospital

Career Start Year 1993

Number of shared co-authors 0

William T Pu

Boston Children's Hospital, Harvard Medical School

Career Start Year 1989

Number of shared co-authors 1

Jianyi Zhang

University of Alabama at Birmingham, 1670 University Boulevard

Career Start Year 1989

Number of shared co-authors 2

Deepak Srivastava

Gladstone Institutes San Francisco

Career Start Year 1989

Number of shared co-authors 0

Daniel J Garry

University of Minnesota

Career Start Year 1986

Number of shared co-authors 1

Sylvia M Evans

University of California at San Diego

Career Start Year 1985

Number of shared co-authors 0

Douglas B Sawyer

Center for Molecular Medicine, Maine Medical Center Research Institute

Career Start Year 1985

Number of shared co-authors 0

Seigo Izumo

Beth Israel Deaconess Medical Center.

Career Start Year 1984

Number of shared co-authors 0

Christine E Seidman

Brigham and Women's Hospital (Y.K.

Career Start Year 1975

Number of shared co-authors 1

row(s) 1 - 30 of 30

Steven S Raman

University of California, Los Angeles David Geffen School of Medicine

Co-authored papers 14

David S K Lu

University of California, Los Angeles David Geffen School of Medicine

Co-authored papers 10

Robert E Reiter

David Geffen School of Medicine at university of california los angeles

Co-authored papers 9

Anthony Sisk

University of California los angeles

Co-authored papers 7

Ely R Felker

University of California, Los Angeles David Geffen School of Medicine

Co-authored papers 6

William Hsu

Co-authored papers 6

William Hsu

American Medical Informatics Association, IEEE, Johns Hopkins University, Radiological Society of North America, University of California Los Angeles, University of California, Los Angeles

Co-authored papers 6

Pooria Khoshnoodi

University of Pittsburgh Medical Center

Co-authored papers 5

Sohrab Afshari Mirak

University Hospitals Cleveland Medical Center/Case Western Reserve University

Co-authored papers 5

James Sayre

David Geffen School of Medicine at university of california los angeles

Co-authored papers 5

Amirali Salmasi

University of California San Diego